Septra and Viracept drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Septra (sulfamethoxazole; trimethoprim) and Viracept (nelfinavir mesylate). Common drug interactions include pancytopenia among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Septra and Viracept. It is created by eHealthMe based on reports of 58 people who take the same drugs from the FDA, and is updated regularly.

What is Septra?

Septra has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 10,280 Septra users. Check the latest studies of Septra.

What is Viracept?

Viracept has active ingredients of nelfinavir mesylate. It is often used in hiv infection. eHealthMe is studying from 6,399 Viracept users. Check the latest studies of Viracept.



On Jul, 26, 2026

58 people who take Septra and Viracept together, and have interactions are studied.

Septra and Viracept drug interactions.

What are the common drug interactions of Septra and Viracept, by gender? *:

female:

  1. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  2. Pregnancy
  3. Abortion induced (medically referred abortion)
  4. Chest pain
  5. Disturbance in attention
  6. Flushing (the warm, red condition of human skin)
  7. Fracture
  8. Haematemesis (vomiting of blood)
  9. Heart rate increased
  10. Insomnia (sleeplessness)

male:

  1. Pyrexia (fever)
  2. Tremor (trembling or shaking movements in one or more parts of your body)
  3. Anger
  4. Anxiety
  5. Aseptic necrosis bone
  6. Aspartate aminotransferase increased
  7. Blood lactate dehydrogenase increased
  8. Confusional state
  9. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  10. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)

What are the common drug interactions of Septra and Viracept, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Anasarca (general swelling, or massive oedema)
  2. Arrhythmia (irregular heartbeat)
  3. Blood potassium increased
  4. Blood sodium decreased
  5. Cellulitis (infection under the skin)
  6. Coma (state of unconsciousness lasting more than six hours)
  7. Dehydration (dryness resulting from the removal of water)
  8. Electrolyte imbalance
  9. Gastroenteritis (inflammation of stomach and intestine)
  10. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)

30-39:

  1. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
  2. Markedly reduced food intake
  3. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  4. Nausea (feeling of having an urge to vomit)
  5. Oedema lower limb (fluid collection in tissue of lower leg)
  6. Oedema peripheral (superficial swelling)
  7. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  8. Ph urine decreased
  9. Pregnancy
  10. Proteinuria present

40-49:

  1. Blood creatinine increased
  2. Abdominal pain
  3. Alanine aminotransferase increased
  4. Aseptic necrosis bone
  5. Aspartate aminotransferase increased
  6. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  7. Pancreatitis (inflammation of pancreas)
  8. Pyrexia (fever)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Blood lactate dehydrogenase increased

50-59:

  1. Dysphagia (a condition in which swallowing is difficult or painful)
  2. Fatigue (feeling of tiredness)
  3. Hiv wasting syndrome (aids wasting syndrome occurs when you have aids and lose at least 10% of your body weight -- especially muscle)
  4. Lipoatrophy (localized loss of fat tissue)
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Myalgia (muscle pain)
  7. Polycythaemia (proportion of blood volume that is occupied by red blood cells increases)
  8. Pruritus (severe itching of the skin)
  9. Pyrexia (fever)
  10. Rash erythematous (redness of the skin)

60+:

  1. Pancreatitis acute (sudden inflammation of pancreas)
  2. Blood amylase increased
  3. Dyspnoea (difficult or laboured respiration)
  4. Palpitations (feelings or sensations that your heart is pounding or racing)
  5. Ventricular extrasystoles (premature cardiac contraction)

What are the existing conditions these people have? *

  1. Insomnia (sleeplessness): 3 people, 5.17%
  2. Depression: 3 people, 5.17%

* Approximation only. Some reports may have incomplete information.

Do you take Septra and Viracept?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Septra and Viracept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Septra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Viracept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Septra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Viracept and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sulfamethoxazole; trimethoprim and nelfinavir mesylate (the active ingredients of Septra and Viracept, respectively), and Septra and Viracept (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: